{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:37:48Z","timestamp":1790807868594,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T00:00:00Z","timestamp":1575936000000},"content-version":"vor","delay-in-days":9,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Natural Science Foundation of China to Innovation Research Group","award":["No. 81621092"],"award-info":[{"award-number":["No. 81621092"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 81670639"],"award-info":[{"award-number":["No. 81670639"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 81670640"],"award-info":[{"award-number":["No. 81670640"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 81870477"],"award-info":[{"award-number":["No. 81870477"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 81870479"],"award-info":[{"award-number":["No. 81870479"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["No. 7172215"],"award-info":[{"award-number":["No. 7172215"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>C3 glomerulonephritis (C3GN) is a rare disease caused by inherited or acquired complement alternative pathway (CAP) dysregulation, which could also be secondary to monoclonal gammopathy of undetermined significance (MGUS). Herein, we described a patient presenting with C3GN and monoclonal gammopathy, and the pathogenic association between the two diseases was further explored in vitro.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>A 76-year-old Chinese man presented with low serum C3 level, haematuria and nephrotic syndrome, and experienced rapid worsening of renal function over a period of 10\u2009months. His serum and urine immunofixation electrophoresis both revealed a monoclonal IgG\u03bb. A bone marrow puncture showed plasma cell dyscrasias with the highest plasma cell count of 5.25%. Kidney biopsy showed the presence of C3 glomerulonephritis, with exclusive deposits of C3 visible on immunofluorescence, a membranoproliferative pattern on light microscopy and electron dense deposits in sub-epithelial, intramembranous, sub-endothelial and mesangial regions by electron microscopy. The patient was positive for C3 nephritic factor (C3NeF) activity and anti-CFH autoantibodies, and all became negative during disease remission. The anti-CFH autoantibodies purified from the patient\u2019s plasma exchange fluids were proven to be a monoclonal IgG\u03bb, and could inhibit CFH binding to C3b and accelerate the formation of C3 convertase indirectly by interfering with the formation-impeding activity of CFH. No deficiency of candidate genes, especially variants in CFH, was detected in our patient. Based on the pathological and laboratory findings, the diagnosis of monoclonal gammopathy of renal significance (MGRS)-associated C3GN was finally made.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This is the first demonstration that intact monoclonal immunoglobulin (IgG\u03bb) could act as an anti-CFH antibody and lead to MGRS-associated C3GN by activating the CAP.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12882-019-1640-3","type":"journal-article","created":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T11:04:07Z","timestamp":1575975847000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Monoclonal immunoglobulin mediates complement activation in monoclonal gammopathy associated-C3 glomerulonephritis"],"prefix":"10.1186","volume":"20","author":[{"given":"Lin-Lin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Xia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Juan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Hui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,10]]},"reference":[{"issue":"8","key":"1640_CR1","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/nrneph.2010.85","volume":"6","author":"F Fakhouri","year":"2010","unstructured":"Fakhouri F, Fremeaux-Bacchi V, Noel LH, Cook HT, Pickering MC. C3 glomerulopathy: a new classification. Nat Rev Nephrol. 2010;6(8):494\u20139.","journal-title":"Nat Rev Nephrol"},{"issue":"6","key":"1640_CR2","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/ki.2013.377","volume":"84","author":"MC Pickering","year":"2013","unstructured":"Pickering MC, D'agati VD, Nester CM, Smith RJ, Haas M, Appel GB, et al. C3 glomerulopathy: consensus report. Kidney Int. 2013;84(6):1079\u201389.","journal-title":"Kidney Int"},{"issue":"2","key":"1640_CR3","doi-asserted-by":"publisher","first-page":"265","DOI":"10.2215\/CJN.07900811","volume":"7","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Meyer NC, Wang K, Nishimura C, Frees K, Jones M, et al. Causes of alternative pathway dysregulation in dense deposit disease. Clin J Am Soc Nephrol. 2012;7(2):265\u201374.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"1640_CR4","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/ki.2012.63","volume":"82","author":"A Servais","year":"2012","unstructured":"Servais A, Noel LH, Roumenina LT, Le Quintrec M, Ngo S, Dragon-Durey MA, et al. Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies. Kidney Int. 2012;82(4):454\u201364.","journal-title":"Kidney Int"},{"issue":"6","key":"1640_CR5","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1093\/ckj\/sfw090","volume":"9","author":"IE Lloyd","year":"2016","unstructured":"Lloyd IE, Gallan A, Huston HK, Raphael KL, Miller DV, Revelo MP, et al. C3 glomerulopathy in adults: a distinct patient subset showing frequent association with monoclonal gammopathy and poor renal outcome. Clin Kidney J. 2016;9(6):794\u20139.","journal-title":"Clin Kidney J"},{"issue":"4","key":"1640_CR6","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/ki.2014.408","volume":"87","author":"F Bridoux","year":"2015","unstructured":"Bridoux F, Leung N, Hutchison CA, Touchard G, Sethi S, Fermand JP, et al. Diagnosis of monoclonal gammopathy of renal significance. Kidney Int. 2015;87(4):698\u2013711.","journal-title":"Kidney Int"},{"issue":"1","key":"1640_CR7","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41581-018-0077-4","volume":"15","author":"N Leung","year":"2019","unstructured":"Leung N, Bridoux F, Batuman V, Chaidos A, Cockwell P, D'agati VD, et al. The evaluation of monoclonal gammopathy of renal significance: a consensus report of the international kidney and monoclonal Gammopathy research group. Nat Rev Nephrol. 2019;15(1):45\u201359.","journal-title":"Nat Rev Nephrol"},{"issue":"9","key":"1640_CR8","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.2215\/CJN.06180710","volume":"6","author":"F Bridoux","year":"2011","unstructured":"Bridoux F, Desport E, Fremeaux-Bacchi V, Chong CF, Gombert JM, Lacombe C, et al. Glomerulonephritis with isolated C3 deposits and monoclonal gammopathy: a fortuitous association? Clin J Am Soc Nephrol. 2011;6(9):2165\u201374.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"1640_CR9","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1053\/j.ajkd.2010.06.021","volume":"56","author":"S Sethi","year":"2010","unstructured":"Sethi S, Sukov WR, Zhang Y, Fervenza FC, Lager DJ, Miller DV, et al. Dense deposit disease associated with monoclonal gammopathy of undetermined significance. Am J Kidney Dis. 2010;56(5):977\u201382.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"1640_CR10","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1053\/j.ajkd.2013.02.370","volume":"62","author":"L Zand","year":"2013","unstructured":"Zand L, Kattah A, Fervenza FC, Smith RJ, Nasr SH, Zhang Y, et al. C3 glomerulonephritis associated with monoclonal gammopathy: a case series. Am J Kidney Dis. 2013;62(3):506\u201314.","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"1640_CR11","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.mayocp.2018.05.019","volume":"93","author":"A Ravindran","year":"2018","unstructured":"Ravindran A, Fervenza FC, Smith RJH, De Vriese AS, Sethi S. C3 Glomerulopathy: ten Years' experience at Mayo Clinic. Mayo Clin Proc. 2018;93(8):991\u20131008.","journal-title":"Mayo Clin Proc"},{"issue":"11","key":"1640_CR12","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1182\/blood-2016-08-737163","volume":"129","author":"S Chauvet","year":"2017","unstructured":"Chauvet S, Fremeaux-Bacchi V, Petitprez F, Karras A, Daniel L, Burtey S, et al. Treatment of B-cell disorder improves renal outcome of patients with monoclonal gammopathy-associated C3 glomerulopathy. Blood. 2017;129(11):1437\u201347.","journal-title":"Blood"},{"key":"1640_CR13","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.3389\/fimmu.2018.02260","volume":"9","author":"S Chauvet","year":"2018","unstructured":"Chauvet S, Roumenina LT, Aucouturier P, Marinozzi MC, Dragon-Durey MA, Karras A, et al. Both monoclonal and polyclonal immunoglobulin contingents mediate complement activation in monoclonal Gammopathy associated-C3 Glomerulopathy. Front Immunol. 2018;9:2260.","journal-title":"Front Immunol"},{"issue":"6","key":"1640_CR14","doi-asserted-by":"publisher","first-page":"A16","DOI":"10.1053\/j.ajkd.2017.08.004","volume":"70","author":"F Daccueil","year":"2017","unstructured":"Daccueil F, Masani NN, D'agati VD, Shirazian S. A 61-year-old man with Membranoproliferative glomerulonephritis. Am J Kidney Dis. 2017;70(6):A16\u201320.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"1640_CR15","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.kint.2018.05.027","volume":"94","author":"S Timmermans","year":"2018","unstructured":"Timmermans S, Van Paassen P, Limburg RR. Conservative treatment for C3 glomerulopathy and monoclonal Ig. Kidney Int. 2018;94(3):632.","journal-title":"Kidney Int"},{"issue":"1","key":"1640_CR16","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.kint.2018.01.037","volume":"94","author":"A Ravindran","year":"2018","unstructured":"Ravindran A, Fervenza FC, Smith RJH, Sethi S. C3 glomerulopathy associated with monoclonal Ig is a distinct subtype. Kidney Int. 2018;94(1):178\u201386.","journal-title":"Kidney Int"},{"issue":"37","key":"1640_CR17","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004843","volume":"95","author":"G Yin","year":"2016","unstructured":"Yin G, Cheng Z, Zeng CH, Liu ZH. C3 glomerulonephritis in multiple myeloma: a case report and literature review. Medicine (Baltimore). 2016;95(37):e4843.","journal-title":"Medicine (Baltimore)"},{"issue":"13","key":"1640_CR18","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1056\/NEJMoa054494","volume":"354","author":"TT Kyle Ra","year":"2006","unstructured":"Kyle Ra TT, Rajkumar SV, Larson DR, Plevak MF, Offord JR, Dispenzieri A, Katzmann JA, Melton LJ 3rd. Prevalence of monoclonal Gammopathy of undetermined significance. N Engl J Med. 2006;354(13):1362\u20139.","journal-title":"N Engl J Med"},{"issue":"4","key":"1640_CR19","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1084\/jem.175.4.939","volume":"175","author":"S Meri","year":"1992","unstructured":"Meri S, Koistinen V, Miettinen A, Tornroth T, Seppala IJ. Activation of the alternative pathway of complement by monoclonal lambda light chains in membranoproliferative glomerulonephritis. J Exp Med. 1992;175(4):939\u201350.","journal-title":"J Exp Med"},{"issue":"8","key":"1640_CR20","doi-asserted-by":"crossref","first-page":"4590","DOI":"10.4049\/jimmunol.163.8.4590","volume":"163","author":"TS Jokiranta","year":"1999","unstructured":"Jokiranta TS, Solomon A, Pangburn MK, Zipfel PF, Meri S. Nephritogenic lambda light chain dimer: a unique human miniautoantibody against complement factor H. J Immunol. 1999;163(8):4590\u20136.","journal-title":"J Immunol"},{"issue":"2","key":"1640_CR21","doi-asserted-by":"publisher","first-page":"141","DOI":"10.4103\/0971-4065.181884","volume":"27","author":"MA Hamzi","year":"2017","unstructured":"Hamzi MA, Zniber A, Badaoui GE, Mahtat E, Alhamany Z, Bayahia R, et al. C3 glomerulopathy associated to multiple myeloma successfully treated by autologous stem cell transplant. Indian J Nephrol. 2017;27(2):141\u20134.","journal-title":"Indian J Nephrol"},{"issue":"1","key":"1640_CR22","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12882-018-0905-6","volume":"19","author":"S Hirashio","year":"2018","unstructured":"Hirashio S, Satoh A, Arima T, Mandai K, Awaya T, Oshima K, et al. Favorable effect of bortezomib in dense deposit disease associated with monoclonal gammopathy: a case report. BMC Nephrol. 2018;19(1):108.","journal-title":"BMC Nephrol"},{"issue":"3","key":"1640_CR23","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1093\/qjmed\/hcx254","volume":"111","author":"GA Ramirez","year":"2018","unstructured":"Ramirez GA, De Luca G, Dell'antonio G, Baldissera E, Suma GV, Tresoldi M, et al. C3-glomerulopathy and MGUS: the skin beyond the kidney. QJM. 2018;111(3):187\u20138.","journal-title":"QJM"},{"issue":"4","key":"1640_CR24","doi-asserted-by":"publisher","first-page":"291","DOI":"10.5414\/CN109300","volume":"89","author":"N Lepori","year":"2018","unstructured":"Lepori N, Cheungpasitporn W, Sethi S, Murray D, Kumar S, Leung N, et al. High-dose melphalan and autologous hematopoietic stem cell transplant in patient with C3 glomerulonephritis associated with monoclonal gammopathy. Clin Nephrol. 2018;89(4):291\u20139.","journal-title":"Clin Nephrol"},{"issue":"1","key":"1640_CR25","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12882-018-0904-7","volume":"19","author":"P Moog","year":"2018","unstructured":"Moog P, Jost PJ, Buttner-Herold M. Eculizumab as salvage therapy for recurrent monoclonal gammopathy-induced C3 glomerulopathy in a kidney allograft. BMC Nephrol. 2018;19(1):106.","journal-title":"BMC Nephrol"},{"key":"1640_CR26","doi-asserted-by":"crossref","unstructured":"Gestur Vidarsson GD, Rispens T. IgG subclasses and allotypes- from structure to effector functions. Front Immunol. 2014;5:520.","DOI":"10.3389\/fimmu.2014.00520"},{"issue":"7","key":"1640_CR27","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.4049\/jimmunol.159.7.3372","volume":"159","author":"SL Roux Kh","year":"1997","unstructured":"Roux Kh SL, Michaelsen TE. Flexibility of human IgG subclasses. J Immunol. 1997;159(7):3372\u201382.","journal-title":"J Immunol"},{"issue":"10","key":"1640_CR28","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1038\/ki.2012.250","volume":"82","author":"D Paixao-Cavalcante","year":"2012","unstructured":"Paixao-Cavalcante D, Lopez-Trascasa M, Skattum L, Giclas PC, Goodship TH, De Cordoba SR, et al. Sensitive and specific assays for C3 nephritic factors clarify mechanisms underlying complement dysregulation. Kidney Int. 2012;82(10):1084\u201392.","journal-title":"Kidney Int"},{"key":"1640_CR29","doi-asserted-by":"crossref","unstructured":"Donadelli R, Pulieri P, Piras R, Iatropoulos P, Valoti E, Benigni A, et al. Unraveling the molecular mechanisms underlying complement Dysregulation by nephritic factors in C3G and IC-MPGN. Front Immunol. 2018;9:2329.","DOI":"10.3389\/fimmu.2018.02329"},{"issue":"11","key":"1640_CR30","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.mayocp.2013.08.002","volume":"88","author":"S Sethi","year":"2013","unstructured":"Sethi S, Rajkumar SV. Monoclonal gammopathy-associated proliferative glomerulonephritis. Mayo Clin Proc. 2013;88(11):1284\u201393.","journal-title":"Mayo Clin Proc"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-019-1640-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-019-1640-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-019-1640-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T20:44:05Z","timestamp":1695501845000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-019-1640-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1640"],"URL":"https:\/\/doi.org\/10.1186\/s12882-019-1640-3","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"28 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study design was approved by the local ethics committee of Peking University First Hospital (No. 20171280) and complied with the Declaration of Helsinki. Written informed consent (No. 1.0) was obtained for blood samples and DNA samples from all individuals.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent from the reported patient for publication was obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"459"}}